Compare RDNT & PAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDNT | PAY |
|---|---|---|
| Founded | 1985 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.6B |
| IPO Year | 1996 | 2021 |
| Metric | RDNT | PAY |
|---|---|---|
| Price | $73.32 | $32.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $94.63 | $40.14 |
| AVG Volume (30 Days) | 481.8K | ★ 677.9K |
| Earning Date | 11-09-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.57 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $1,616,630,000.00 | $1,196,507,000.00 |
| Revenue This Year | $22.90 | $21.19 |
| Revenue Next Year | $12.36 | $17.87 |
| P/E Ratio | ★ N/A | $89.31 |
| Revenue Growth | 13.05 | ★ 37.25 |
| 52 Week Low | $50.82 | $20.11 |
| 52 Week High | $85.84 | $45.31 |
| Indicator | RDNT | PAY |
|---|---|---|
| Relative Strength Index (RSI) | 55.96 | 51.14 |
| Support Level | $66.67 | $29.13 |
| Resistance Level | $78.97 | $34.16 |
| Average True Range (ATR) | 2.22 | 1.20 |
| MACD | 0.56 | 0.16 |
| Stochastic Oscillator | 72.35 | 66.00 |
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
Paymentus Holdings Inc provides electronic bill presentment and payment services, enterprise customer communication and self-service revenue management to billers through a Software-as-a-Service (SaaS), secure, omni-channel technology platform. The platform integrates with a biller's financial and operational systems to provide secure and flexible processing of payments, including credit cards, debit cards, eChecks, and digital wallets, across multiple channels such as online, mobile, IVR, call centers, chatbots, and voice-based assistants. The company generates the majority of its revenue from payment transaction fees processed through its platform. Geographically, it derives the maximum revenue from the United States.